- Home
- MED vs PRQR Comparison
MED vs PRQR Comparison
Compare MED & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- PRQR
- Stock Information
- Founded
- MED 1980
- PRQR 2012
- Country
- MED United States
- PRQR Netherlands
- Employees
- MED N/A
- PRQR N/A
- Industry
- MED Packaged Foods
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- MED Consumer Staples
- PRQR Health Care
- Exchange
- MED Nasdaq
- PRQR Nasdaq
- Market Cap
- MED 152.3M
- PRQR 179.1M
- IPO Year
- MED N/A
- PRQR 2014
- Fundamental
- Price
- MED $13.93
- PRQR $1.94
- Analyst Decision
- MED Hold
- PRQR Strong Buy
- Analyst Count
- MED 1
- PRQR 7
- Target Price
- MED $16.50
- PRQR $9.00
- AVG Volume (30 Days)
- MED 228.5K
- PRQR 289.9K
- Earning Date
- MED 08-04-2025
- PRQR 08-07-2025
- Dividend Yield
- MED N/A
- PRQR N/A
- EPS Growth
- MED N/A
- PRQR N/A
- EPS
- MED N/A
- PRQR N/A
- Revenue
- MED $543,452,000.00
- PRQR $21,212,711.00
- Revenue This Year
- MED N/A
- PRQR $2.87
- Revenue Next Year
- MED N/A
- PRQR N/A
- P/E Ratio
- MED N/A
- PRQR N/A
- Revenue Growth
- MED N/A
- PRQR 85.91
- 52 Week Low
- MED $11.57
- PRQR $1.07
- 52 Week High
- MED $22.66
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- MED 55.96
- PRQR 61.65
- Support Level
- MED $12.85
- PRQR $1.77
- Resistance Level
- MED $14.91
- PRQR $2.03
- Average True Range (ATR)
- MED 0.60
- PRQR 0.10
- MACD
- MED 0.06
- PRQR 0.01
- Stochastic Oscillator
- MED 60.32
- PRQR 75.86
About MED MEDIFAST INC
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.